Modulation of monocyte chemotactic function in inflammatory lesions. Role of inflammatory mediators
I M Katona(Uniformed Services University of the Health Sciences), Sharon M. Wahl(National Institutes of Health), Kiyoshi Ohura(National Institute of Dental and Craniofacial Research), Dennis E. Chenoweth(National Institute of Dental and Craniofacial Research), J B Allen(University of Vermont), L M Wahl(National Institutes of Health)
Cited by 30
Related Papers
Suppression of arthritis by an inhibitor of nitric oxide synthase.
|The Journal of Experimental Medicine|1993|652
Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa.
|The Journal of Experimental Medicine|1992|325
Systemic and Local Interleukin-17 and Linked Cytokines Associated with Sjögren’s Syndrome Immunopathogenesis
|American Journal Of Pathology|2009|304
Macrophage- and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome.
|The Journal of Experimental Medicine|1991|293
Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta.
|The Journal of Experimental Medicine|1990|263